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Accepted 25 July 2013Intake of high-fructose corn syrup (HFCS) has been suggested to contribute to the increased
prevalence of obesity, whereas a number of studies and organizations have reported
metabolic equivalence between HFCS and sucrose. We hypothesized that HFCS and sucrose
would have similar effects on energy-regulating hormones and metabolic substrates at
normal levels of human consumption and that these values would not change over a
10-week, free-living period at these consumption levels. This was a randomized, pros-
pective, double-blind, parallel group study in which 138 adult men and women consumed
10 weeks of low-fat milk sweetened with either HFCS or sucrose at levels of the 25th, 50th,
and 90th percentile population consumption of fructose (the equivalent of 40, 90, or 150 g of
sugar per day in a 2000-kcal diet). Before and after the 10-week intervention, 24-hour blood
samples were collected. The area under the curve (AUC) for glucose, insulin, leptin, active
ghrelin, triglyceride, and uric acid was measured. There were no group differences at
baseline or posttesting for all outcomes (interaction, P > .05). The AUC response of glucose,
active ghrelin, and uric acid did not change between baseline and posttesting (P > .05),
whereas the AUC response of insulin (P < .05), leptin (P < .001), and triglyceride (P < .01)
increased over the course of the intervention when the 6 groups were averaged.
We conclude that there are no differences in the metabolic effects of HFCS and sucrose
when compared at low, medium, and high levels of consumption.
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Obesity1. Introduction
Intake of added sugars along with many other nutrients has
increased significantly in the United States in the last 40
years—for the 35-year period between 1970 and 2005, Amer-
icans' average daily intake of sugar increased from 400 to 476
calories, a 19% increase [1]. During the same period, there has
also been a dramatic increase in obesity in the United States
and many other countries [2].ciation; AUC, area under
ute, Shrewsbury, MA 015
(J. Rippe).
er Inc. All rights reservedConcerned over the potential that added sugars might be a
contributing factor to obesity, a number of organizations have
recommended a decrease in added sugar consumption.
Recommended upper limits of consumption of added sugars
from the AmericanHeart Association (AHA) [3] aremuchmore
restrictive than those of the Institute of Medicine [4] upon
which the Dietary Guidelines for Americans are based [5].
It has also been argued that high-fructose corn syrup
(HFCS), in particular, may be uniquely related to the increasedthe curve; BMI, body mass index; HFCS, high-fructose corn syrup.
45. Tel.: +1 508 756 1306; fax: +1 508 754 5098.
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between the appearance of HFCS in the American diet as a
significant component of added sugars and the rise in obesity
[6]. Numerous studies, however, have demonstrated the
metabolic equivalence of HFCS and sucrose [7-9] either in
acute experiments or in short-term studies where either HFCS
or sucrose was consumed at levels up to 25% of calories (90th
percentile population consumption level of fructose) as part of
mixed nutrient diets. Both the American Medical Association
[10] and the Academy of Nutrition and Dietetics [11] have
issued statements supporting the metabolic equivalence of
HFCS and sucrose. Several studies have implicated a role for
sucrose, particularly when consumed in sugar-sweetened
beverages in promoting obesity [12].
The debate on added sugars and their relationship to
obesity and other potential metabolic problems has been
further fueled by research studies comparing pure fructose vs
pure glucose [13,14], although neither pure fructose nor pure
glucose is consumed to any appreciable degree in the human
diet. Fructose and glucose are virtually always consumed
together, most commonly as components of sucrose or HFCS
[15]. It has also been argued that the fructose moiety in
sweetened beverages interacts differently with energy-regu-
lating hormones such as insulin, leptin, and ghrelin, promot-
ing a situation where excess calories may be consumed
without appropriate satiety signals, thereby increasing the
likelihood of weight gain and obesity [6,12,16]. It has also been
argued that the 10% difference in fructose found in HFCS-55
(the most common form of HFCS used in beverages), when
compared with sucrose, might further create metabolic
abnormalities because of the well-known difference in
metabolism between fructose and glucose in the liver [17,18].
In addition, it has been argued that excessive consump-
tion of fructose from sugar-sweetened beverages may re-
sult in an increased triglyceride production [19-24]. In
particular, it has been argued that postprandial triglycerides
may be particularly elevated after large doses of fructose-
containing sugars through the process of de novo lipogenesis
in the liver [13,25,26].
There is a debate that HFCS may behave differently from
sucrose because HFCS has free fructose and glucose, whereas
sucrose has fructose and glucose bound as a disaccharide.
Several issues are important to note about this debate. First,
the bond between fructose and glucose is immediately broken
in the small intestine by the enzyme sucrase. Therefore, it is
absorbed as free fructose and free glucose. Second, slightly
acidic environments or warmth cause this bond to be broken
(the process of inversion). Thus, in carbonated soft drinks,
which are mildly acidic, if sucrose were used as a sweetener,
it would be highly likely that a high percentage of it had
already been inverted to glucose and fructose. Furthermore, in
our research laboratory, we have shown in acute experiments
that HFCS and sucrose behave virtually identically. Nonethe-
less, because this remains controversial, we felt that it was
important to conduct a longer-term study comparing HFCS
with sucrose and with both at various doses within the range
of human consumption.
The purpose of the current study was to extend previous
observations related to acute responses of glucose, energy-
regulating hormones, and metabolic substrates by exploring3 different levels of added sweetener consumption from
either HFCS or sucrose (25th, 50th, and 90th percentile popu-
lation consumption levels of fructose [27] in a randomized,
prospective, double-blind, parallel group study. We hypoth-
esized that there would be no differences in the concentra-
tion of metabolic substrates or energy-regulating hormones
at any level of added sugar consumption within the normal
human range when comparing HFCS and sucrose and that
the acute metabolic effects of HFCS and sucrose would not
change as a result of a10-week intervention of daily exposure
to these sugars.2. Methods and materials
2.1. Design and participants
This study was a randomized, prospective, double-blind,
parallel group study comparing the effects of 3 different
doses of HFCS-55 (55% fructose) with comparable doses of
sucrose (50% fructose) on circulating concentrations of hor-
mones regulating bodyweight and appetite (insulin, leptin, and
active ghrelin). Participants were randomly assigned to 1 of 6
groups by following an order dictated by a random sequence
generated from a free Web site (random.org). Participants
consumed 8%, 18%, or 30% of calories in low-fat (1% fat) milk
(Tetra Pak, Denton, TX, USA) sweetened with either HFCS-55 or
sucrose (representing the 25th, 50th, and 90th percentile
population consumption levels of fructose). This corresponds
to 40, 90, or 150 g of added sugar per day in a 2000-kcal diet.
Low-fat milk was used to enhance participant compliance over
the 10-week study. Furthermore, previous investigations that
used carbonated soft drinks suffered from the confounding
problem of significant inversion of sucrose into its components
of fructose and glucose because of the mildly acidic environ-
ment of these beverages.We believed that this would not occur
with low-fat milk. The stability of the sugars used was
confirmed by outside, blinded analysis conducted by Archer
Daniels Midland (Argenta, IL, USA). Participants participated in
an initial 24-hour stay in our metabolic unit, followed by 10
weeks of free-living consumption of these levels of added
sugar, followed by another 24-hour acute stay in our metabolic
unit. The experimental protocol was approved by the Western
Institutional Review Board.
The study population included men and women between
the ages of 20 and 60 years, with a body mass index (BMI)
between 21 and 35 kg/m2. Participants were recruited from
newspaper advertisements, postings on the Internet, and a
database of individuals who had participated in previous
studies in our research laboratory who had indicated a desire
to participate in further research trials. All participants were
weight stable (no change in weight >3% in the past month, no
actions taken in 3 months to lose weight), nonsmokers (not
been a regular smoker for at least 12 months and no social
smoking for at least 3 months), and normoglycemic (fasting
after a 2-hour oral glucose challenge). Participants were
excluded if they had uncontrolled blood pressure, a history
of thyroid disease, cancer, gastrointestinal disorders, cardiac
problems, or eating disorders; if they had ever had a surgical
procedure for weight loss; if they had undergone any major
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newmedication within the past 3 months (including a change
in dose of an existing medication); if they were pregnant or
lactating; if they consumed more than 3 alcoholic drinks per
week; or if they had any significant food allergy. In addition,
participantswere not allowed to enroll if they had participated
in any other clinical trial within the previous 30 days. All
participants provided signed informed consent. All proce-
dures of this study and the informed consent were approved
by the Western Institutional Review Board.
Participants were randomly assigned to 1 of 6 groups:
• Groups 1 and 2: energy balanced containing 8% calories
from HFCS or sucrose
• Groups 3 and 4: energy balanced containing 18% calories
from HFCS or sucrose
• Groups 5 and 6: energy balanced containing 30% calories
from HFCS or sucrose
The sugar was supplied via premixed, sugar-sweetened,
low-fatmilk supplied to them in8-oz, unlabeled, sealed cartons.
Themilkwas supplied incartons containingeither 15gofadded
sugar per 8-oz ounce carton or 30 g of sugar per 8-oz carton to
provide the same volume of milk for each participant and,
hence, the same volume of naturally occurring sugars from the
milk. Compliance to milk consumption was measured with
daily dietary logs, which were handed in on a weekly basis
when participants returned to our clinic facility to receive the
weekly supply of milk. A weight maintenance caloric intake
levelwascalculatedusing theMifflinSt Jeorpredictionequation
[28] (and appropriate activity factor based on self-reported
levels of habitual physical activity), and milk was then
prescribed in an amount necessary to meet the desired %
HFCS or sucrose content of the diet. Participants had unlimited
flexibility in themakeup of the remainder of their diet but were
instructed on the need to account for the calories from themilk
if they wanted to maintain their initial bodymass. Participants
were instructed to eat to the same level of “fullness.”
2.2. Metabolic unit procedures
Participants performed 2 overnight stays in the metabolic
unit, one after completion of screening and one after 10
weeks of intervention, as described by Melanson et al [7]. In
summary, a fasting blood sample was obtained at 8:00 AM via
an intravenous catheter. A standardized breakfast was
provided at 9:00 AM, after which blood samples were obtained
every 30 minutes until midnight and hourly thereafter until
8:00 AM on day 2 of the visit. Additional standardized meals
were provided for lunch and dinner. Each meal was accom-
panied by the test beverage of the group to which they were
assigned. All meals were standardized for energy and
macronutrient content and consumed within 15 minutes of
being served to ensure standardization of nutrient appear-
ance in the blood stream.
2.3. Anthropometric measurements
Anthropometric measurements were taken before the
study in all participants. Body composition in the beginningand the end of study was determined by iDXA (GE Medical
Systems, Madison, WI, USA). Fasting-state, multiple mea-
sures were taken, and percent body fat and lean body mass
were obtained.
2.4. Blood serum measurements
Blood samples obtained in the metabolic unit were used to
measure glucose, insulin, leptin, active ghrelin, and triglycer-
ides. Blood was collected in BD (Becton Dickinson, Franklin
Lakes, NJ, USA) vacutainers containing ethylenediaminetetraa-
cetic acid for the preparation of plasma. Immediately after
collecting blood samples, serine protease inhibitor (Pefabloc SC
[AEBSF], 1 mg/mL sample; Roche Diagnostic Cooperation,
Indianapolis, IN, USA) were added to prevent the degradation
of active ghrelin molecule. Aliquots from collected samples
were stored at −80 C until tested. Bloods for insulin, leptin, and
active ghrelin were tested in batches once an adequate number
of pretesting and posttesting samples had been obtained.
Plasma glucose was measured using the YSI 2300 analyzer
(YSI Life Sciences, Yellow Springs, OH, USA). Plasma insulin,
leptin, and active ghrelin were assayed simultaneously using
MILLIPLEX MAP Human Metabolic Hormone Panel (EMD Milli-
pore, St Charles, MO, USA). Assays were run on Luminex 200
(Luminex Corporation, Austin, TX, USA) with xPONENT soft-
ware. Additional blood was obtained in a standard Serum
Separator BD vacutainer and allowed to clot, and then the
serumwas obtained and stored as described for plasma. These
serum sampleswere used for themeasurement of triglycerides
and uric acid by CPL Laboratories (Orlando, FL, USA) using
standard techniques.
2.5. Statistical analyses
All data are presented as means ± SD and analyzed using
SPSS-PASW Statistics (version 19; SPSS, Chicago, IL, USA).
Twenty-four-hour area under the curve (AUC) was measured
for all analytes measured in the metabolic unit using the
trapezoidal method and was not calculated for participants
with more than 3 consecutive missing values or for those
without a baseline or final (8:00 AM) value. Outcome measures
were analyzed via a 2-way analysis of variance with repeated
measures (6 groups × 2 time points). Significant differences
among groups at different dosages were assessed using
preplanned LS means comparisons. Statistical significance
was defined by P < .05.3. Results
3.1. Demographic information
A total of 465 participants who enrolled met the qualifying
criteria, completed fasting baseline testing, and began the
intervention. A subset of 141 participants were enrolled in the
substudy requiring the overnight visit, with 138 participants
(male, 79; female, 59), finishing the intervention, and perform-
ing the second overnight visit. Baseline descriptive data on
these 138 are shown in Table 1. Baseline dietary intake for all
groups is presented in Table 2.
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reasons including noncompliance with milk consumption,
dissatisfaction with time commitment, new job, or other
personal commitments. No participant reported any adverse
effects from the interventions.
3.2. Body mass and body composition
There were overall increases in all measures of adiposity for
the entire cohort—bodymass (76.9 ± 13.9 kg vs 78.0 ± 14.5 kg, P <
.001), BMI (27.0 ± 3.6 kg/m2 vs 27.4 ± 3.7 kg/m2, P < .001), waist
circumference (84.7 ± 9.8 cm vs 85.0 ± 10 cm, P < .05), body fat
percentage (33.6% ± 8.8% vs 34.1% ± 8.7%, P < .001), fat mass
(25.3 ± 10.9 kg vs 26.1 ± 8.9 kg, P < .001), and fat-freemass (52.3 ±
10.9 kg vs 52.7 ±11.0 kg, P < .001). However, in all cases, there
were no differences among the groups in the change from
pretesting to posttesting (time × group interaction, P > .05).
3.3. Metabolic unit data
Fasting values of glucose, insulin, leptin, ghrelin, triglycerides,
and uric acid were not different among the groups at base-
line or week 10 (P > .05). After 10 weeks, whole-day AUC
was increased in the entire cohort for insulin (5848 ± 2655 vs
6271 ± 3372, P < .05), leptin (347 ± 305 h * μg/L vs 386 ± 325 h *
μg/L, P < .001), and triglycerides (29.5 ± 17.0 mmol/L vs 32.3 ±
16.4 mmol/L, P < .001), but were unchanged for glucose, ghrelin,
and uric acid (P > .05). In all cases, there were no differences in
the response to the 6 different interventions at baseline or
posttesting (interaction, P > .05; Table 2). Daily fluctuations
in insulin (Fig. 1), leptin (Fig. 2), ghrelin (Fig. 3), and triglycerides
(Fig. 4) are shown in Figs. 1–4.
There were no differences among the groups in dietary
intake at baseline. Study participants failed to completely
accommodate the calories from the low-fat, sugar-sweet-
ened milk as evidenced by an overall increase in energy
intake over the course of 10 weeks, as shown in Table 3.
This increase was larger in sucrose 30% than in HFCS 8%
and larger in HFCS 30% than in both 8% groups. There was
also a greater increase in the proportion of calories that
came from carbohydrates in both 30% groups compared with
sucrose 8%, but not when compared with HFCS 8%. The
sucrose 8% group also showed a smaller decrease in
the proportion of calories from fat compared with both the
sucrose 18% and HFCS 30% groups.Table 1 – Participant characteristics
Entire cohort
(n = 138)
HFCS 8%
(n = 20) a
Sucro
(n =
Age (y) 38.3 ± 11.3 39.1 ± 11.8 32.8
Weight (kg) 79.3 ± 13.5 79.6 ± 13.8 82.2
BMI (kg/m2) 27.4 ± 3.5 28.2 ± 3.9 28.2
Systolic blood pressure (mm Hg) 110.1 ± 9.3 106.6 ± 8.9 111.3
Diastolic blood pressure (mm Hg) 72.9 ± 7.4 70.2 ± 6.9 72.2
Glucose (mmol/L) 4.9 ± 0.4 4.9 ± 0.3 5.0
Values are means ± SD.
a Beverages included HFCS- or sucrose-sweetened low-fat milk supplyin4. Discussion
This study compared themetabolic effects of 3 different levels
of sucrose and HFCS-55 under randomized, controlled,
blinded conditions in men and women between the ages of
20 and 60 years. The two, 1-day experimental visits to our
metabolic units were separated by 10 weeks of free living
where individuals consumed 8%, 18%, or 30% of calories in a
eucaloric, mixed nutrient diet. This study confirmed our
hypothesis that there would be no difference between HFCS
and sucrose with regard to effects on energy-regulating
hormones and that these values would not change over a
10-week free-living period at these consumption levels. These
findings provide further validation of the acute findings that
our research team published related to the equivalence of
HFCS and sucrosewhen delivered at average population levels
for a 24-hour period [7]. These findings also provide further
information concerning the difference between results when
comparing the commonly consumed sugars of HFCS and
sucrose as comparedwith themore artificial condition of pure
fructose vs pure glucose where differences in energy-regulat-
ing hormones have been demonstrated. In addition, these
findings provide evidence contrary to what Maersk et al [29],
Ventura et al [17], and Goran et al [18] have speculated that the
additional 10% of fructose in HFCS-55 might make metabolic
differences when compared with sucrose.
It has been argued that HFCS and sucrose may behave
differently in metabolism and physiology. There are 2 com-
ponents of this argument. First, people argue that the
bond between glucose and fructose in sucrose may make it
behave differently when it is compared with HFCS where
fructose and glucose are not bonded together. However,White
and others [15] have argued that the bond between fructose
and glucose in sucrose is rapidly broken by the sucrase en-
zyme in the small intestine, and thus, HFCS and sucrose are
both absorbed in an identical fashion as fructose and glucose.
Second, it has been argued by Goran and others [18] that the
10% difference in fructose may be caused by differences in
metabolism between HFCS and sucrose. Our data do not sup-
port this speculation.
The 24-hour postprandial hormone profiles (insulin, leptin,
ghrelin) and metabolic substrates (glucose, triglyceride, uric
acid) were not significantly different between HFCS- and
sucrose-sweetened milk at 3 different consumption levelsse 8%
25)
HFCS 18%
(n = 26)
Sucrose 18%
(n = 23)
HFCS 30%
(n = 23)
Sucrose 30%
(n = 21)
± 10.7 38.7 ± 10.9 40.2 ± 10.4 42.2 ± 11.5 37.2 ± 12.5
± 15.0 78.6 ± 12.8 80.1 ± 14.0 77.5 ± 12.3 75.5 ± 12.6
± 3.9 27.7 ± 3.4 26.6 ± 3.3 27.8 ± 3.5 25.9 ± 3.5
± 8.7 110.4 ± 7.7 108.6 ± 8.8 113.4 ± 10.0 109.2 ± 9.9
± 7.3 73.4 ±7.7 83.2 ± 6.2 75.0 ± 9.0 72.1 ± 6.3
± 0.4 5.0 ± 0.4 5.0 ± 0.4 5.0 ± 0.3 4.9 ± 0.3
g 8%, 18%, or 30% of calories, respectively.
Table 2 – Baseline dietary intake before beginning 10 weeks of daily consumption of sugar-sweetened, low-fat milk a
Entire cohort
(n = 138)
HFCS 8%
(n = 20)
Sucrose 8%
(n = 25)
HFCS 18%
(n = 26)
Sucrose 18%
(n = 23)
HFCS 30%
(n = 23)
Sucrose 30%
(n = 21)
Energy intake (kcal) 2102.3 ± 689.0 2142.9 ± 738.5 2245.9 ± 605.3 2066.0 ± 591.6 2079 ± 642.8 1838.5 ± 581.8 2292.5 ± 957.5
% Energy from fat 32.4 ± 7.0 30.7 ± 5.8 30.2 ± 6.5 33.3 ± 6.8 35.2 ± 6.8 34.4 ± 7.0 30.3 ± 8.3
% Energy from carbohydrate 48.0 ± 8.0 48.2 ± 7.1 48.6 ± 7.8 46.2 ± 8.2 47.7 ± 7.1 48.1 ± 8.6 50.0 ± 9.4
% Energy from protein 18.3 ± 5.1 19.1 ± 5.2 19.7 ± 6.5 19.4 ± 5.1 15.8 ± 2.5 16.7 ± 4.6 18.7 ± 5.2
Saturated fat (g) 25.8 ± 12.3 24.6 ± 10.3 26.2 ± 11.2 26.5 ± 12.9 29.1 ± 16.5 24.0 ± 10.5 24.5 ± 13.0
Total fiber (g) 18.9 ± 8.9 18.9 ± 7.3 18.7 ± 5.8 16.8 ± 9.0 17.9 ± 6.5 17.5 ± 11.2 24.4 ± 11.2
Values are means ± SD.
a Beverages included HFCS- or sucrose-sweetened low-fat milk supplying 8%, 18%, or 30% of calories respectively.
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research published by our group, in which the acutemetabolic
effects of sucrose and HFCS consumption at 30% of energy
on circulating glucose, insulin, leptin, and ghrelin were com-
pared in normal-weight women [7] and found to be virtually
identical. In another study, 24-hour AUC response of glucose,
leptin, and ghrelin during the consumption of HFCS-sweet-
ened beverages were not significantly different from those
when sucrose-sweetened beverages were consumed and
when participants have included overweight and obese popu-
lation and men [9]. The current study provided evidence for
the equivalent metabolic response between HFCS and sucrose800
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Fig. 1 – Fluctuation of insulin throughout the day before and afte
intervention groups at baseline or posttesting (interaction, P > .05)
the intervention (P < .05), but there was no difference among the
averages at each time point for all participants in each condition.
supplying 8%, 18%, or 30% calories, respectively.after long-term (10-week) consumption of HFCS- and sucrose-
sweetened beverages at 3 different dosage levels within the
reference range of human consumption for added fructose.
Fructose's metabolism through energy regulatory hor-
mones has been proposed as a possiblemechanism to explain
trends in HFCS consumption and obesity. Fructose does not
stimulate insulin secretion from pancreatic islets [30]. Of
particular importance, insulin may play a pivotal role in the
sequence of events that lead to increased satiety with the
ingestion of most carbohydrates [31]. As such, elevated blood
glucose and, subsequently, increased circulating insulin can
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The lack of differences in leptin response among groups
observed in this study is not surprising because of similar
responses in plasma glucose in the postprandial state.
A number of epidemiologic studies have reported an asso-
ciation between sugar-sweetened beverage consumption and
increased energy intake and obesity in children and adults [35-
37]. One recentmeta-analysis evaluated 88 cross-sectional and
prospective studies and that higher intake of sugar-sweetened
beverages was associated with greater body weight, greater
energy intake, and lower intake of other nutrients [38]. Because
weight gain, overweight, and obesity represent complicated
metabolic conditions, however, it would appear unlikely that a
single foodor food group is primarily causal [39,40]. In contrast,
several meta-analyses and literature reviews have reviewed
clinical trials and concluded that fructose intake, even up to
the 95th percentile population consumption level of fructose,
was not associatedwith increased likelihood of obesity [41,42].
A recent systematic review and meta-analysis by Sievenpiper
and colleagues [43] suggested that fructose did not seem to
cause weight gain when it was substituted for other carbohy-
drates in diets providing similar calories. In contrast, whenfructose was supplied at high doses providing excess calories,
a modest increase in the body weight occurred. These in-
vestigators speculated that this effect may be caused by
the added extra calories rather than the fructose per se [43].
The current study appears to add additional credence to the
concept that isocaloric substitution of fructose-containing
sugars in up to the 90th percentile of consumption levels for
fructose does not create a hormonal environment that would
promote the likelihood of obesity.
In the current study, there were no differences in glucose,
insulin, leptin, or ghrelin when consumed at 8%, 18%, or 30%
of calories in a mixed nutrient diet. Furthermore, there were
no differences in any of these parameters when comparing
acute measurements at the beginning or the trial and after
the 10 weeks of free living where individuals consumed these
various levels of sugars. To put this in perspective, the 8%
consumption of calories from added sugars (40 g of added
sugar in a 2000-kcal diet) represents the 25th percentile popu-
lation consumption level for fructose and is approximately
the upper level amount of calories from added sugars recom-
mended by the AHA not to be exceeded by adult men (the
recommendation for adult women is even lower). The 18%
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Fig. 3 – Fluctuation of active ghrelin throughout the day before and after the study. There were no differences among 6 different
intervention groups at baseline or posttesting (interaction, P > .05). There was no change in AUC active ghrelin in the entire
cohort (P > .05), and there was no difference among the groups (interaction, P > .05). All measurements represent averages at
each time point for all participants in each condition. Beverages included HFCS- or sucrose-sweetened low-fat milk supplying
8%, 18%, or 30% calories, respectively.
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sugar in a 2000-kcal diet) in the current study represents 2 to
3 times the upper limit recommended by the AHA, whereas
the 30% consumption of calories from added sugars (150 g of
added sugar in a 2000-kcal diet) in the current study repre-
sents approximately 4 times the upper limits recommended
by the AHA [3] and is similar to the upper limit of 25%
established by the Institute of Medicine in the Dietary Refer-
ence Intakes for carbohydrates [4]. It should also be noted that
there were no differences between HFCS and sucrose in any
parameter at any dosage level. Our data are consistent with
the systematic review andmeta-analysis of controlled feeding
trials published by Cozma et al [44], which concluded that
isocaloric exchange of fructose for other carbohydrates im-
proved long-termglycemic control without effecting insulin in
people with diabetes.
Diabetes Associations have typically taken the approach
of setting an upper threshold of the intake of fructose or
fructose-containing sugars based on potential adverse effects
on serum lipids. The American Diabetes Association [45]
guidelines acknowledge that fructose produces a lower
glycemic response in individuals with diabetes and replaces
sucrose and starch in the diet. However, it does not providespecific recommendations about sugar consumption other
than to state that the “mix of carbohydrate, protein and fat
may be adjusted to meet the metabolic goals and individual
preferences of the person with diabetes.” The British Diabetes
Association [46], European Association for the Study of Dia-
betes [47], and Canadian Diabetes Association [48] all have
various recommendations for optimal diet in people with type
2 diabetes. However, these recommendations focus on the
percentage of calories from carbohydrates, protein, and fat
without specific recommendations for dietary sugars.
It has been postulated that excessive consumption of fruc-
tose can result in increased blood pressure through the
metabolism of adenosine triphosphate to adenosine mono-
phosphate and, ultimately, to uric acid [16]. Uric acid is pos-
tulated to contribute to endothelial dysfunction, which could
ultimately result in increased blood pressure [16]. In the cur-
rent study, there were no differences in uric acid in response
to any of the conditions or either of the added sugars. Most of
the previous research done in this area has explored fructose
delivered in boluses by itself, in large quantities, or in animal
models. Our data would suggest that increases in uric acid do
not occur when fructose and glucose are consumed together
at normal population consumption levels. Our data are also
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Fig. 4 – Fluctuation of triglyceride throughout the day before and after the study. There were no differences among 6 different
intervention groups at baseline or posttesting (interaction, P > .05). In the entire cohort, AUC triglyceride increased over the
course of the intervention (P < .01), but there was no difference among the groups (interaction, P > .05). All measurements
represent averages at each time point for all participants in each condition. Beverages included HFCS- or sucrose-sweetened
low-fat milk supplying 8%, 18%, or 30% calories, respectively.
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controlled feeding trials published by Wang et al [49], which
did not find support for uric acid increasing the effects of
isocaloric dose intake in nondiabetic or diabetic participants.
It has also been argued that fructose consumption can
result in an increased triglyceride production through the
process of de novo lipogenesis [13]. It has been further arguedTable 3 – Changes in energy and macronutrient intake (before-
sugar-sweetened, low-fat milk a
Entire cohort
(n = 138)
HFCS 8%
(n = 20)
Sucrose 8
(n = 25)
Energy intake (kcal) 333.1 ± 662.8 ⁎⁎⁎ −67.0 ± 520.8 55.2 ± 785
% Energy from fat −8.0 ± 8.3 ⁎⁎⁎ −5.1 ± 5.2 ⁎⁎ −2.9 ± 6.8
% Energy from carbohydrate 2.4 ± 7.1 ⁎⁎⁎ 5.3 ± 7.6 ⁎⁎ 2.4 ± 7.1
% Energy from protein 0.8 ± 4.7 ⁎ 1.2 ± 6.0 2.0 ± 4.6
Values are means ± SD.
a Beverages included HFCS- or sucrose-sweetened low-fat milk supplyin
⁎ Significant change from baseline, P < .05.
⁎⁎ Significant change from baseline, P < .01.
⁎⁎⁎ Significant change from baseline, P < .001.that this process may be exacerbated when fructose and
glucose are consumed together because glucose enters the
glycogenetic pathway, leaving fructose only the de novo lipo-
genesis pathway [29,30]. Although these qualitative differ-
ences may occur, it is not clear whether the quantity of lipids
produced through de novo lipogenesis is meaningful in the
overall energy economy. In the current study, there were noafter) over the course of 10 weeks of daily consumption of
% HFCS 18%
(n = 26)
Sucrose 18%
(n = 23)
HFCS 30%
(n = 23)
Sucrose 30%
(n = 21)
.0 416.9 ± 542.9 ⁎⁎ 280.3 ± 566.5 716.6 ± 566.5 ⁎⁎⁎ 552.9 ±661.7 ⁎⁎
−7.5 ± 9.9 ⁎⁎ −11.5 ± 7.9 ⁎⁎⁎ −11.6 ± 8.1 ⁎⁎⁎ −9.7 ± 7.3 ⁎⁎⁎
9.7 ± 12.0 ⁎⁎ 10.2 ± 9.7 ⁎⁎⁎ 10.9 ± 9.5 ⁎⁎⁎ 11.6 ± 9.6 ⁎⁎⁎
−1.2 ± 4.9 2.4 ± 2.4 1.6 ± 4.8 −0.8 ± 4.2
g 8%, 18%, or 30% of calories, respectively.
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regard to postprandial triglycerides. The expected increase in
triglycerides occurred after every eating occasion, but no dif-
ferences were found among 3 different levels of added sugars.
The slight rise in fasting triglycerides has been observed after
higher carbohydrate diets, particularly with simple sugars,
and merits further investigation [19]. It should be noted that
added sugars were provided in low-fat milk in the current
study. Thus, the effects of the supplemental proteins in the
milk might have interfered with the effects of the sugar and
reduced triglyceride excursions. It has been reported that
patients on protein supplement can decrease intrahepatic
lipids and alter lipoprotein kinetics [50-52]. The use of low-fat
milk as a delivery vehicle for the various sweeteners repre-
sents an additional limitation because providing groups with
different amounts of vitamin Dmay have impacted on results.
Strengths of the current study include the relatively large
sample size and the tight control over both acute and free-
living diet consumptions. Weaknesses include the high
dropout rate and perhaps the decision not to include
adolescents, which is the highest sugar-sweetened beverage
consumption group in the United States. It should also be
noted that this study was conducted for a 10-week period. It is
possible that a longer exposure to these levels of sugars might
impact on the results. Furthermore, fructose could not be
directly measured, which should be taken into consideration
in interpreting these results.
The finding that HFCS and sucrose at 3 different levels of
normal human consumption up to the 90th percentile con-
sumption of fructose behave similarly with regard to energy-
regulating hormones and that there are no differences
between the 3 different doses and no changes over 10-
weeks provides evidence that speculation that there may be
differences between HFCS and sucrose does not appear to
apply to normal human consumption levels. This isocaloric
trial provides further evidence that fructose and glucose
supplied together do not create a hormonal environment
that would promote obesity. This finding is consistent with
systematic analyses and meta-analyses published by Sie-
venpiper and colleagues [43]. These findings provide further
evidence that calories consumed appear to be more impor-
tant in promoting obesity than any particular kind of
carbohydrate consumed.
The current study suggests that the strategy of signifi-
cantly restricting sugar-sweetened beverages as a component
of an overall strategy to combat obesity may not rest on any
solid research basis. Furthermore, longer-term trials to resolve
this issue appear warranted.Acknowledgment
James Rippe's research organization has received funding,
and he has received consulting fees from ConAgra Foods,
PepsiCo International, Kraft Foods, the Corn Refiners Associ-
ation, and Weight Watchers International. The current study
was supported by an unrestricted grant from the Corn
Refiners Association. Zhiping Yu and Joshua Lowndes have
no conflicts of interest.R E F E R E N C E S
[1] Wells HF, Buzby JC. Dietary assessment of major trends in the
US food consumption, 1970-2005, Economic Information
Bullertin No. 33. Economic Research Service, U.S. Dept. of
Agriculture: Beltsville, MD; 2008.
[2] Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of
obesity and trends in the distribution of body mass index
among US adults, 1999-2010. JAMA 2012;307:491–7.
[3] Johnson RK, Appel LJ, Brands M, Howard BV, Lefevre M, Lustig
RH, et al. Dietary sugars intake and cardiovascular health: a
scientific statement from the American Heart Association.
Circulation 2009;120:1011–20.
[4] Trumbo P, Schlicker S, Yates AA, Poos M. Food, Nutrition
Board of the Institute of Medicine TNA. Dietary reference
intakes for energy, carbohydrate, fiber, fat, fatty acids,
cholesterol, protein and amino acids. J Am Diet Assoc
2002;102:1621–30.
[5] Services USDoAaUSDoHaH. Dietary Guidelines for
Americans, 2010. 7th ed.Washington, DC: U.S. Government
Printing Office; 2010.
[6] Bray GA, Nielsen SJ, Popkin BM. Consumption of
high-fructose corn syrup in beverages may play a role in
the epidemic of obesity. Am J Clin Nutr 2004;79:537–43.
[7] Melanson KJ, Angelopoulos TJ, Nguyen V, Zukley L,
Lowndes J, Rippe JM. High-fructose corn syrup, energy
intake, and appetite regulation. Am J Clin Nutr 2008;88:
1738S–44S.
[8] Soenen S, Westerterp-Plantenga MS. No differences in satiety
or energy intake after high-fructose corn syrup, sucrose, or
milk preloads. Am J Clin Nutr 2007;86:1586–94.
[9] Stanhope KL, Griffen SC, Bair BR, Swarbrick MM, Keim NL,
Havel PJ. Twenty-four-hour endocrine and metabolic profiles
following consumption of high-fructose corn syrup-,
sucrose-, fructose-, and glucose-sweetened beverages with
meals. Am J Clin Nutr 2008;87:1194–203.
[10] Association AM. Report 3 of the Council on Science and Public
Health (A-08); 2008.
[11] American Dietetic Association. Position of the American
Dietetic Association: use of nutritive and nonnutritive
sweeteners. J Am Diet Assoc 2004;104:255–75.
[12] Bray GA. Fructose: pure, white, and deadly? Fructose, by any
other name, is a health hazard. J Diabetes Sci Technol 2010;4:
1003–7.
[13] Teff KL, Grudziak J, Townsend RR, Dunn TN, Grant RW,
Adams SH, et al. Endocrine and metabolic effects of
consuming fructose- and glucose-sweetened beverages with
meals in obese men and women: influence of insulin
resistance on plasma triglyceride responses. J Clin Endocrinol
Metab 2009;94:1562–9.
[14] Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA,
Graham JL, et al. Consuming fructose-sweetened, not
glucose-sweetened, beverages increases visceral adiposity
and lipids and decreases insulin sensitivity in overweight/
obese humans. J Clin Invest 2009;119:1322–34.
[15] White JS, Foreyt JP, Melanson KJ, Angelopoulos TJ.
High-fructose corn syrup. controversies and common sense.
Am J Lifestyle Med 2010;4:515–20.
[16] Johnson RJ, Segal MS, Sautin Y, Nakagawa T, Feig DI, Kang DH,
et al. Potential role of sugar (fructose) in the epidemic of
hypertension, obesity and the metabolic syndrome, diabetes,
kidney disease, and cardiovascular disease. Am J Clin Nutr
2007;86:899–906.
[17] Ventura EE, Davis JN, Goran MI. Sugar content of popular
sweetened beverages based on objective laboratory analysis:
focus on fructose content. Obesity (Silver Spring) 2010;19:
868–74.
1052 N U T R I T I O N R E S E A R C H 3 3 ( 2 0 1 3 ) 1 0 4 3 – 1 0 5 2[18] Goran MI, Ulijaszek SJ, Ventura EE. High fructose corn syrup
and diabetes prevalence: a global perspective. Glob Public
Health 2013;8:55–64.
[19] Hellerstein MK. Carbohydrate-induced hypertriglyceridemia:
modifying factors and implications for cardiovascular risk.
Curr Opin Lipidol 2002;13:33–40.
[20] Mensink RP, Zock PL, Kester AD, Katan MB. Effects of dietary
fatty acids and carbohydrates on the ratio of serum total to
HDL cholesterol and on serum lipids and apolipoproteins: a
meta-analysis of 60 controlled trials. Am J Clin Nutr 2003;77:
1146–55.
[21] Appel LJ, Sacks FM, Carey VJ, Obarzanek E, Swain JF, Miller III
ER, et al. Effects of protein, monounsaturated fat, and
carbohydrate intake on blood pressure and serum lipids:
results of the OmniHeart randomized trial. JAMA 2005;294:
2455–64.
[22] Fried SK, Rao SP. Sugars, hypertriglyceridemia, and
cardiovascular disease. Am J Clin Nutr 2003;78:873S–80S.
[23] Bantle JP, Raatz SK, Thomas W, Georgopoulos A. Effects of
dietary fructose on plasma lipids in healthy subjects. Am J
Clin Nutr 2000;72:1128–34.
[24] Chong MF, Fielding BA, Frayn KN. Mechanisms for the acute
effect of fructose on postprandial lipemia. Am J Clin Nutr
2007;85:1511–20.
[25] Lustig R. Letter to the editor. J Am Diet Assoc 2011;111:990–3.
[26] Hudgins LC, Parker TS, Levine DM, Hellerstein MK. A dual
sugar challenge test for lipogenic sensitivity to dietary
fructose. J Clin Endocrinol Metab 2011;96:861–8.
[27] Marriott BP, Cole N, Lee E. National estimates of dietary
fructose intake increased from 1977 to 2004 in the United
States. J Nutr 2009;139:1228S–35S.
[28] Mifflin MD, St Jeor ST, Hill LA, Scott BJ, Daugherty SA,
Koh YO. A new predictive equation for resting energy
expenditure in healthy individuals. Am J Clin Nutr 1990;51:
241–7.
[29] Maersk M, Belza A, Stødkilde-Jørgensen H, Ringgaard S,
Chabanova E, Thomsen H, et al. Sucrose-sweetened
beverages increase fat storage in the liver, muscle, and
visceral fat depot: a 6-mo randomized intervention study.
Am J Clin Nutr 2012;95:283–9.
[30] Rodin J. Effects of pure sugar versus mixed starch fructose
loads on food intake. Appetite 1991;17:213–9.
[31] Woods SC, Lotte rEC, McKay LD, Porte Jr D. Chronic
intracerebroventricular infusion of insulin reduces food
intake and body weight of baboons. Nature 1979;282:503.
[32] Havel PJ. Dietary fructose: implications for dysregulation of
energy homeostasis and lipid/carbohydrate metabolism.
Nutr Rev 2005;63:133–57.
[33] Schwartz MW, Woods SC, Porte DJ, Seeley RJ, Baskin DG.
Central nervous system control of food intake. Nature
2000;404:61–671.
[34] Friedman JM. Leptin, leptin receptors, and the control of body
weight. Nutr Rev 1998;56:s54–75.
[35] Malik VS, Schulze MB, Hu FB. Intake of sugar-sweetened
beverages and weight gain: a systematic review. Am J Clin
Nutr 2006;84:274–88.
[36] Malik VS, Popkin BM, Bray GA, Despres JP, Hu FB. Sugar-
sweetened beverages, obesity, type 2 diabetes mellitus, and
cardiovascular disease risk. Circulation 2010;121:1356–64.[37] Bachman CM, Baranowski T, Nicklas TA. Is there an
association between sweetened beverages and adiposity?
Nutr Rev 2006;64:153–74.
[38] Vartanian LR, Schwartz MB, Brownell KD. Effects of soft
drink consumption on nutrition and health: a systematic
review and meta-analysis. Am J Public Health 2007;97:
667–75.
[39] Glickman DPL, Slim LJ, Del Valle Cook H, Miller EA, editors.
Committee on Accelerating Progress in Obesity Prevention;
Food and Nutrition Board; Institute of Medicine of the
National Academies: accelerating progress in obesity
prevention: solving theweight of the nation.Washington, DC:
The National Academies Press; 2012.
[40] Hall KD, Heymsfield SB, Kemnitz JW, Klein S, Schoeller DA,
Speakman JR. Energy balance and its components:
implications for body weight regulation. Am J Clin Nutr
2012;95:989–94.
[41] Dolan LC, Potter SM, BurdockGA. Evidence-based reviewon the
effect of normal dietary consumption of fructose on develop-
ment of hyperlipidemia and obesity in healthy, normal weight
individuals. Crit Rev Food Sci Nutr 2010;50:53–84.
[42] Dolan LC, Potter SM, Burdock GA. Evidence-based review on
the effect of normal dietary consumption of fructose on blood
lipids and body weight of overweight and obese individuals.
Crit Rev Food Sci Nutr 2010;50:889–918.
[43] Sievenpiper JL, de Souza RJ, Mirrahimi A, Yu ME, Carleton AJ,
Beyene J, et al. Effect of fructose on body weight in controlled
feeding trials: a systematic review and meta-analysis. Ann
Intern Med 2012;156:291–304.
[44] Cozma AI, Sievenpiper JL, de Souza RJ, Chiavaroli L, Ha V,
Wang DD, et al. Effect of fructose on glycemic control in
diabetes: a systematic review andmeta-analysis of controlled
feeding trials. Diabetes Care 2012;35:1611–20.
[45] Position statement: standards of medical care in
diabetes—2012. Diabetes Care 2012;35(Suppl 1):S11–63.
[46] Nutrition Committee of the British Diabetic Association's
Professional Advisory Committee. Dietary recommendations
for people with diabetes: an update for the 1990s. Diabet Med
1992;9:189–202.
[47] Diabetes and Nutrition Study Group (DNSG) of the European
Association for the Study of Diabetes (EASD). 1. Diabetes Nutr
Metab 1995;8:186–9.
[48] National Nutrition Committee CDA. Guidelines for the
nutritional management of diabetes mellitus in the new
millennium: a position statement by the Canadian Diabetes
Association. Can J Diabetes Care 1999;23:56–69.
[49] Wang D, Sievenpiper JL, de Souza R, Chiavaroli L, Ha V, Cosma
A, et al. The effects of fructose intake on serum uric acid vary
among controlled dietary trials. J Nutr 2012;142:916–23.
[50] Bortolotti M, Kreis R, Debard C, Cariou B, Faeh D, Chetiveaux
M, et al. High protein intake reduces intrahepatocellular lipid
deposition in humans. Am J Clin Nutr 2009;90:1002–10.
[51] Bortolotti M, Dubuis J, Schneiter P, Tappy L. Effects of dietary
protein on lipidmetabolism in high fructose fed humans. Clin
Nutr 2012;31:238–45.
[52] Theytaz F, Noguchi Y, Egli L, Campos V, Buehler T, Hodson L,
et al. Effects of supplementation with essential amino acids
on intrahepatic lipid concentrations during fructose
overfeeding in humans. Am J Clin Nutr 2012;96:1008–16.
